Loading...
Gland Pharma Ltd — Levothyroxine Export Profile: Buyers & Destinations
Loading...
Indian Pharmaceutical Exporter · #8 for Levothyroxine · $750.0K export value · DGFT Verified
Gland Pharma Ltd is the #8 Indian exporter of Levothyroxine with $750.0K in export value and 15 verified shipments. Gland Pharma Ltd holds a 1.0% market share in Levothyroxine exports across 1 countries.
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $47.6M | 952 | 64.6% |
| PERU | $7.7M | 153 | 10.4% |
| UNITED KINGDOM | $6.8M | 209 | 9.3% |
| AUSTRALIA | $5.3M | 132 | 7.3% |
| CHILE | $1.6M | 33 | 2.2% |
| CANADA | $1.5M | 53 | 2.1% |
| KAZAKHSTAN | $1.1M | 49 | 1.5% |
| DOMINICAN REPUBLIC | $528.6K | 55 | 0.7% |
| VIETNAM | $325.6K | 8 | 0.4% |
| VENEZUELA | $301.6K | 37 | 0.4% |
India exports Levothyroxine to 71 countries. The top destination is UNITED STATES (64.6%), followed by PERU and UNITED KINGDOM.
| Buyer | Country | Value | Orders |
|---|---|---|---|
| EVERSANA LIFE SCIENCES SERVICES,LLC | UNITED STATES | $8.9M | 341 |
| WOCKHARDT UK LIMITED | UNITED KINGDOM | $5.2M | 103 |
| SUN PHARMA ANZ PTY LTD | AUSTRALIA | $3.5M | 92 |
| EVERSANA LIFE SCIENCES SERVICES LLC | UNITED STATES | $3.2M | 107 |
| MYLAN PHARMACEUTICALS INC 3711 COLLINS FERRY ROAD |
India exported $60.1M worth of Levothyroxine through 2,385 shipments from 125 suppliers to 71 countries, serving 235 buyers globally. Gland Pharma Ltd contributes $750.0K to this total, accounting for 1.0% of India's Levothyroxine exports.
Gland Pharma Ltd's average Levothyroxine shipment value is $50.0K per consignment, based on 15 shipments totaling $750.0K.
Gland Pharma Ltd ranks #8 among 125 Indian Levothyroxine exporters with a 1.0% market share. The top 3 exporters are INTAS PHARMACEUTICALS LIMITED ($14.7M), MACLEODS PHARMACEUTICALS LTD ($13.9M), STERIL-GENE LIFE SCIENCES PRIVATE LIMITED ($9.4M). Gland Pharma Ltd processed 15 shipments to 1 destination countries.
What Gland Pharma Ltd must comply with to export Levothyroxine to its top destination countries
Approval Process
ANDA (Abbreviated New Drug Application) for generics. Indian manufacturing site must pass FDA pre-approval inspection. Drug Master File (DMF) required for APIs.
Timeline: 10–18 months for ANDA approval
GMP & Export Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA
Drug Listing with FDA; Export Certificate from CDSCO India; Import Alert screening via FDA PREDICT system
Note: Subject to FDA Import Alerts. Open Form 483 observations can block all exports from a facility.
Approval Process
Exporters ranked immediately above and below #8 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 11 | ROGER MEDICALS | $1.1M | 49 | 1 | $22.2K |
| 9 | GLAND PHARMA LIMITED | $800.0K | 16 | 2 | $50.0K |
| 8 | GLAND PHARMA LTD ★ | $750.0K | 15 | 1 | $50.0K |
| 13 | INTAS PHARMACEUTICALS LTD | $329.9K | 9 | 1 | $36.7K |
| 15 |
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 257 | 10.8% |
| MUNDRA SEA | 257 | 10.8% |
| DELHI AIR CARGO ACC (INDEL4) | 207 | 8.7% |
| NHAVA SHEVA SEA (INNSA1) | 207 | 8.7% |
| MUNDRA SEA (INMUN1) | 179 | 7.5% |
| SAHAR AIR | 165 | 6.9% |
| DELHI AIR | 120 | 5.0% |
| JNPT/ NHAVA SHEVA SEA | 98 | 4.1% |
Latest developments and market context
Detailed market intelligence for Levothyroxine — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Gland Pharma Ltd's Levothyroxine exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
| UNITED STATES |
| $2.1M |
| 42 |
| BONAPHARM S.A.C.. | PERU | $1.2M | 24 |
| ALEMBIC PHARMACEUTICALS SPA | CHILE | $1.1M | 21 |
| MACLEODS PHARMA USA,INC, | UNITED STATES | $800.0K | 16 |
| EVERSANA | UNITED STATES | $550.0K | 11 |
| EVERSANA LIFE SCIENCE SERVICES LLC | UNITED STATES | $350.0K | 7 |
India's Levothyroxine is purchased by 235 buyers worldwide. The top buyer is EVERSANA LIFE SCIENCES SERVICES,LLC (UNITED STATES), followed by WOCKHARDT UK LIMITED and SUN PHARMA ANZ PTY LTD.
Post-Brexit UK Marketing Authorisation via national procedure. Separate from EU approval since January 2021.
Timeline: 12–15 months
GMP & Export Requirements
UK GMP compliance; MHRA inspection of manufacturing site
Manufacturer Import Authorisation (MIA) held by UK importer; Qualified Person (QP) batch release
Note: Post-Brexit: EU GMP certificates no longer automatically valid in UK. Separate MHRA recognition required.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
| ACME GENERICS LLP |
| $239.1K |
| 25 |
| 6 |
| $9.6K |
Gland Pharma Ltd ranks #8 among 125 Indian Levothyroxine exporters. Average shipment value of $50.0K compared to the market average of $481.0K. The closest competitors by value are ROGER MEDICALS and GLAND PHARMA LIMITED.
Verify manufacturer licensing and export certifications with the official agencies above.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 71+ countries, 235+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Access shipment-level records, pricing trends, and buyer contacts for Gland Pharma Ltd.
Request DemoView Pricing →Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Levothyroxine. For current shipment-level data, contact TransData Nexus.